Cargando…
Studies in a Murine Model Confirm the Safety of Griffithsin and Advocate Its Further Development as a Microbicide Targeting HIV-1 and Other Enveloped Viruses
Griffithsin (GRFT), a lectin from Griffithsia species, inhibits human immunodeficiency virus-1 (HIV-1) replication at sub-nanomolar concentrations, with limited cellular toxicity. However, in vivo safety of GRFT is not fully understood, especially following parenteral administration. We first assess...
Autores principales: | Kouokam, Joseph Calvin, Lasnik, Amanda B., Palmer, Kenneth E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127025/ https://www.ncbi.nlm.nih.gov/pubmed/27869695 http://dx.doi.org/10.3390/v8110311 |
Ejemplares similares
-
Investigation of Griffithsin's Interactions with Human Cells Confirms Its Outstanding Safety and Efficacy Profile as a Microbicide Candidate
por: Kouokam, Joseph Calvin, et al.
Publicado: (2011) -
Novel Antifungal Activity of Q-Griffithsin, a Broad-Spectrum Antiviral Lectin
por: Nabeta, Henry W., et al.
Publicado: (2021) -
Improving the large scale purification of the HIV microbicide, griffithsin
por: Fuqua, Joshua L, et al.
Publicado: (2015) -
Antiviral lectin Q-Griffithsin suppresses fungal infection in murine models of vaginal candidiasis
por: Nabeta, Henry W., et al.
Publicado: (2022) -
Pharmacokinetics of the Antiviral Lectin Griffithsin Administered by Different Routes Indicates Multiple Potential Uses
por: Barton, Christopher, et al.
Publicado: (2016)